Vycor Medical Company Description
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe.
It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries.
The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury.
It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals.
The company was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.
| Country | United States |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Peter Zachariou |
Contact Details
Address: 951 Broken Sound Boulevard Boca Raton, Delaware 33487 United States | |
| Phone | 561 558 2000 |
| Website | vycormedical.com |
Stock Details
| Ticker Symbol | VYCO |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US92921M2035 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Peter C. Zachariou | Chief Executive Officer and Director |
| David Marc Cantor | President and Director |
| Adrian Christopher Liddell | Chairman and Chief Financial Officer |